Your browser doesn't support javascript.
loading
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Grabner, Alexander; Schramm, Karla; Silswal, Neerupma; Hendrix, Matt; Yanucil, Christopher; Czaya, Brian; Singh, Saurav; Wolf, Myles; Hermann, Sven; Stypmann, Jörg; Di Marco, Giovana Seno; Brand, Marcus; Wacker, Michael J; Faul, Christian.
Afiliação
  • Grabner A; Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Schramm K; Division of Nephrology, Department of Medicine, Duke University Medical Center, Duke University, Durham, North Carolina, USA.
  • Silswal N; Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Hendrix M; Department of Cell Biology and Anatomy, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Yanucil C; Department of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Czaya B; Department of Biomedical Sciences, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
  • Singh S; Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Wolf M; Department of Cell Biology and Anatomy, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Hermann S; Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Stypmann J; Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Di Marco GS; Department of Cell Biology and Anatomy, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Brand M; Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Wacker MJ; Katz Family Drug Discovery Center and Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Faul C; Department of Cell Biology and Anatomy, University of Miami Miller School of Medicine, Miami, Florida, USA.
Sci Rep ; 7(1): 1993, 2017 05 16.
Article em En | MEDLINE | ID: mdl-28512310

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Hipertrofia Ventricular Esquerda / Receptor Tipo 4 de Fator de Crescimento de Fibroblastos / Fatores de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Hipertrofia Ventricular Esquerda / Receptor Tipo 4 de Fator de Crescimento de Fibroblastos / Fatores de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos